Physician profile
Scott Turner
NPI 1578681961
$8,505.90
in general payments reported to CMS, 2019-2025
38 companies · $1,547 in 2025
The $1,547 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,213 · 2020: $781 · 2021: $1,156 · 2022: $1,163 · 2023: $1,340 · 2024: $1,306 · 2025: $1,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,775 · Travel and Lodging: $302 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,774.56 |
| Travel and Lodging | $301.74 |
| Education | $116.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,703.66 | 2021-2025 | Corevalve Evolut R, Micra, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $1,092.14 | 2019-2020 | |
| Abbott Laboratories | $903.01 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Novartis Pharmaceuticals Corporation | $839.49 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $374.48 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $356.84 | 2019-2025 | |
| Abiomed | $275.45 | 2020-2025 | Impella |
| Edwards Lifesciences Corporation | $205.96 | 2019-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $182.34 | 2019-2024 | Polaris Ultra, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $178.51 | 2022-2024 | Lifevest |
| Cleerly, INC. | $123.58 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Chiesi USA, INC. | $116.77 | 2019-2023 | Kengreal, Cleviprex |
| Siemens Medical Solutions USA, INC. | $115.99 | 2020 | |
| Zoll Respicardia, INC. | $99.19 | 2023 | Remede System |
| Philips North America LLC | $96.46 | 2024 | (Am5) Lead Management |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $96.45 | 2019-2023 | Xarelto |
| Zoll Circulation INC | $88.91 | 2021-2024 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Scpharmaceuticals INC. | $85.63 | 2025 | |
| Vifor Pharma, INC. | $78.87 | 2020 | |
| Cvrx, INC. | $53.39 | 2024-2025 | Barostim Neo System |
| Ethicon US, LLC | $45.79 | 2025 | Vistaseal, Stratafix, Dermabond |
| Stryker Corporation | $42.92 | 2025 | Flowsaver, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $39.44 | 2021-2023 | Farxiga |
| Surmodics, INC. | $35.26 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Bayer Healthcare Pharmaceuticals INC. | $35.06 | 2025 | |
| Inari Medical, INC. | $32.11 | 2022 | |
| Amgen INC. | $24.38 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $21.04 | 2022 | |
| Merck Sharp & Dohme LLC | $18.44 | 2024 | Verquvo |
| Cardiovascular Systems INC. | $18.43 | 2020 | |
| Astellas Pharma US INC | $18.04 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.41 | 2025 | Jardiance |
| Reflow Medical INC | $15.90 | 2025 | |
| Gilead Sciences, INC. | $15.70 | 2019 | |
| Baxter Healthcare | $15.43 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Cook Medical LLC | $15.23 | 2019 | |
| Contego Medical, INC | $14.76 | 2024 | |
| Argentum Medical | $13.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.